Specialized early-stage tech-centric ventures with market-entry challenges have 7 potential new allies.
Accelerator takeoffs, Marijuana, TechStars visit, capital raises and more.
[Updated 7 December 2013] Angel sees numerous exits ahead from among more on the 25 companies already in his portfolio
The Row's Galante eyes startups and Crom's at it again, as well as Ganier, Van Hoesen and others.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: